Janssen submits supplemental new drug application to FDA seeking expanded pediatric indication for HIV-1 therapy Edurant
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental New Drug Application (sNDA) to the FDA seeking to expand the indication of Edurant… read more.
